We have previously demonstrated that human cytomegalovirus (CMV) binds the host protein fl2microglobulin (fl2m) from body fluids or from cell culture media. In this report we have examined the effect of the fl2m on viral infectivity. We have shown that the addition of human purified/~2m, or a fraction of foetal calf serum corresponding to bovine f12 m, to culture medium increased the amount of infectious extracellular CMV, compared to that from cells grown in serum-free medium. Metabolic labelling experiments demonstrated that this effect was not due to an increase in the amount of extracellular virus but to an increase in the infectivity of the virus present in extracellular fluids. We concluded that the binding of ]~2m by CMV increased its infectivity. We have shown that CMV and /~2m compete for binding sites on 
INTRODUCTION
Human cytomegalovirus (CMV) is a ubiquitous agent which has a complex relationship with its host. We have previously reported that CMV grown in cell culture has the capacity to bind the host protein P2 microglobulin (fl2m) . The ]~2m binding capacity of CMV was found to reside in two viral envelope proteins, flzm BP1 and fl2m BP2 , and we have calculated that in the order of 105 molecules of fl2m were bound per infectious virus particle (McKeating et al., 1986) . We have shown that in body fluids in vivo, CMV exists as flzm-coated particles . The binding offl2m to CMV was found to mask the viral antigenic determinants so that the viral glycoproteins could not be recognized by CMV-specific monoclonal antibodies (McKeating et al., 1986) . Farthermore the flzm-coated virus found naturally in urine specimens could not be neutralized by hyperimmune globulin, human immune sera or murine monoclonal antibodies that could neutralize CMV grown in cell culture . We concluded that the binding of fl2m by CMV masked the important antigenic sites necessary for neutralization and postulated that the virus had evolved this mechanism of coating itself in a host protein as a means of evading the host immune response.
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These findings raise an important fundamental question. If the viral envelope glycoproteins important for neutralization are effectively masked by the binding offlzm, what surface proteins does CMV use to bind to, and initiate infection in, host cells? Since the virus purified from urine was shown to be infectious for cell cultures in the neutralization experiments referred to above, two possible explanations can be put forward; either a small proportion of 'uncoated' viral particles were responsible for the observed infectivity or the fl2m-coated particles themselves were infectious. The finding that the urinary virus could not be neutralized by a variety of antibodies specific for CMV proteins argues against the former hypothesis. To test the latter hypothesis, we have studied the effect of fl2m on the infectivity of CMV, and have investigated the binding of flEm-coated particles to host cells.
METHODS
Cell culture. Human foreskin fibroblasts were cultured at 37 °C in 10% CO 2 in Eagle's MEM (EMEM; Gibco) supplemented with antibiotics, glutamine and 3% or 10% foetal calf serum (FCS) (Flow Laboratories) or with a serum substitute, 2% Ultroser G (UG) (LKB) as indicated. Cells were maintained in the respective media for at least ten passages before use. In some experiments the FCS was separated into various fractions, as described below. CMV-seronegative human serum at 3 % or purified human f12 m at 2 p.g/ml were used as media supplements where indicated.
Raji and Daudi lymphoblastoid cell lines were obtained from Flow Laboratories and maintained in RPMI 1640 medium (Flow) supplemented with antibiotics, glutamine and 10% heat-inactivated FCS.
Fractionation of FCS. Where indicated in the text FCS was separated into two fractions, with molecular masses greater than or less than 25 000 daltons by ultrafiltration using an Amicon filter cone (GF25). The concentrate was reconstituted to its original volume with phosphate-buffered saline (PBS). In one experiment the low molecular mass fraction was further separated as follows. Fifty ml of this fraction was loaded onto a 16 cm x 80 cm Sephadex G-75 (Pharmacia) column prepared in 0.9% saline solution. This was washed with 200 ml saline solution and eluted with 0.1% NaN3 in H20 at a rate of 100 ml/h. Fractions of 10 ml each were collected every 6 rain and stored at -20 °C. The column was pre-calibrated using molecular mass standards (Pharmacia).
Production of cell culture-grown CMV. For virus stocks CMV strain AD169 was propagated in fibroblasts in EMEM with 3% FCS, and culture supernatant was harvested when 80 to 90% of the cells showed c.p.e.
In experiments where other media supplements were used, cells grown in the medium indicated were infected with stock virus for I h at 37 °C and the medium was replaced with the experimental medium. Extracellular virus was harvested from the culture medium after clarification at 2000 g for 15 rain. Intracellular virus was obtained after trypsinization of cells by freezing and thawing three times followed by ultrasonication for 2 min in an ultrasonic water bath and clarification as above.
Purification of CMVfrom urine. Urine known to contain CMV by virus isolation was clarified at 1500g for 15 min and concentrated by ultrafiltration using an Amicon stirred cell concentrator with membranes having a molecular mass cutoff of 100000. Concentrated urine was centrifuged through a potassium tartrate/glycerol negative viscosity/positive density gradient (Talbot & Almeida, 1977) at 400000 g for 45 min. The diffuse band representing the virions was harvested.
Infectivity of virus preparations. Virus preparations were titrated in 10-fold dilutions and inoculated onto fibroblasts grown in serum-free medium plus 2% UG in 96-well microtitre plates. Eight replicates of each virus dilution were assayed. Wells were observed after 14 days for the occurrence of c.p.e, and the minimum virus dose that caused c.p.e, in 50% of the wells, the TCIDso, was calculated by the Kaerber method.
Labelling with radioiodide in vitro. CMV strain ADI69, gradient-purified as for urinary virus, purified urinary CMV or purified flzm were radiolabelled with t2sI using the iodogen method (Fraker & Speck, 1978) . Unincorporated isotope was removed by ultrafiltration using Amicon G25 filter cones for the virus preparations or by gel filtration through Sephadex G-50 (Pharmacia) for fl2m, Radiolabellingofviralproteins in cellculture. Fibroblasts cultured in the media indicated were infected with CMV strain AD 169 at a m.o.i, of 1.0 and at various times post-infection the cells were washed in PBS and the medium was replaced with methionine-free EMEM (Flow) for 3 h. After repeated washing [35S]methionine was added at 5 laCi/ml for 24 h. Extracellular virus was harvested by ultracentrifugation at 400000g for 1 h. The pellet was resuspended in PBS and the radioactivity present was counted in a gamma counter.
Measurement of class I HLA antigen expression on cells~ Raji or Daudi cells were washed three times in HEPESbuffered EMEM (Flow) containing 2% bovine serum albumin (BSA) with centrifugation at 500 g for 12 min. Cells were plated at 107 cells per well in 96-well flexible microtitre trays (Dynatech) and reacted with twofold dilutions of the monoclonal antibodies W6/32 (ATCC Hybridoma No. HB95) BBM. 1 (ATCC Hybridoma No. HB28) or RF6 (Royal Free Hospital) for 1 h at 4 °C. Eight replicates were used at each dilution. These monoclonal antibodies are specific for class I HLA heavy chain (Brodsky et al., 1979) , fl2m (Brodsky et al., 1979) and hepatitis B surface antigen respectively. The cells were washed as before and binding of the monoclonal antibodies was detected by an l~SI-labelled rabbit anti-mouse antibody (Amersham). Wells were again washed, cut out and the radioactivity bound to cells was measured in a gamma counter.
Binding of radiolabelled urinary CMV, CMV strain ADI69 or fl2m to cells. Fibroblasts were seeded at 10'* cells/well in 96-well tissue culture plates (Flow) in EMEM with 3 % FCS and cultured for 3 h. Monolayers were washed three times with HEPES-buffered EMEM containing 2% BSA. 12SI-labelled urinary CMV, CMV strain AD169 or fl2m was added at twofold dilutions from 5 x 106 c.p.m/ml to 1.5 x 105 c.p.m./ml for 1 h at 0 °C with eight replicates at each dilution. Monolayers were washed as before and 100 ~tl of 0.05 M-NaOH was added to each well for 15 min at room temperature. The resultant cell lysate was harvested and radioactivity was counted in a gamma counter.
The binding of radiolabelled virus or fl2m to Daudi and Raji cells was performed in a similar manner except that the plates, washing and harvesting procedures used were as described for the measurement of HLA antigens on these cells.
The effect of unlabelled target competition of the binding of t25I-labelled urinary CMV or fl2m to cells by unlabelled urinary CMV or strain AD169 was investigated as follows. 1251-labelled purified urinary CMV was added to cells at 5 x 105 c.p.m./ml. Unlabelled urinary CMV or CMV strain AD169 of known titre, or fl2m, was serially diluted in EMEM, added to the cells at the same time as the radiolabelled agent, and binding of the latter was measured as above.
Infectivity of CMVfor Raft and Daudi cells. Raji or Daudi cells were suspended at 4 × 105 cells/ml and incubated
with CMV strain AD169 at a m.o.i, of 1.0 for 1 h at 37 °C with rotation. After washing, cells were cultured for 4 days, harvested and viable counts were performed using trypan blue exclusion. Cells were fixed and stained with a pool of monoclonal antibodies specific for CMV early antigens (Pereira et al., 1982) as previously described (Griffiths et al., 1984) . The percentage of cells expressing early antigens was enumerated by immunofluorescence after counting a total of 1300 cells.
RESULTS

Effect of fl2m or FCS in culture medium on the amount of infectious extracellular virus
Fibroblasts were cultured in serum-free medium with 2% UG, infected with CMV strain AD169 at a m.o.i, of 1.0, and fresh medium was added with or without purified human fl2m or 3 % FCS. Extracellular virus was harvested at 3, 5, 6 and 7 days post-infection and the amount of infectious virus was assayed. Fig. 1 shows that the addition of either human fl2m or FCS to the culture medium substantially increased the amount of infectious extracellular virus compared to that from cells grown in serum-free medium alone.
Effect of various FCS fractions on the amount of infectious extracellular and intracellular virus
FCS contains bovine flzm (molecular mass 11700), and it was possible that this protein was responsible for the increase in the amount of infectious virus released from cells grown in the presence of FCS. A preliminary separation of FCS into low (< 25 000) and high (> 25 000) molecular mass fractions was performed, and the experiment above was repeated using media supplemented with the various fractions or with 3 % non-immune human serum. At four days post-infection both intracellular and extracellular virus was harvested and infectivity assayed. Table 1 shows that the amount of infectious extracellular virus when cells were cultured in the low molecular mass fraction of FCS was equivalent to that seen when whole FCS was used. In contrast cells grown in the presence of the high molecular mass fraction of FCS produced as little infectious extracellular virus as those grown in serum-free medium alone. The addition of human serum also increased the amount of infectious extracellular virus. The difference in extracellular virus titres in cells grown in the presence of whole FCS, the low molecular mass fraction of FCS or human serum, compared to that from serum-free medium was significant (P < 0-001, P < 0.001 and P < 0.01 respectively) whereas the high molecular mass fraction did not significantly increase the titre. There was no obvious trend in the effect of the various media supplements on the amount of intracellular virus.
Thus it is clear that the factor in FCS responsible for the increase in the amount of infectious extracellular virus was in the fraction < 25 000 daltons. Fig. 2 shows a titration of this fraction into serum-free culture medium, and it can be seen that above a concentration of 2 % the amount of infectious extracellular virus rose steeply, reaching a plateau at a concentration of 4%. or with the addition of 2 ~tg/ml fl2m CA) or 3 ~ FCS (11). Extracellular virus was harvested at days 3, 5, 6 and 7 and titrated on fibroblasts grown in serum-free medium. Fig. 2 . Effect of various concentrations of the low molecular mass fraction of FCS, added to fibroblasts grown in serum-free medium, on the output of infectious extracellular CMV strain AD169. Virus was harvested at 4 days post-infection and titrated on fibroblasts grown in serum-free medium. 2.5 2.6 3~ Human serum 1.5 0.7 * Fibroblasts were cultured in serum-free medium, infected with CMV strain AD169 at m.o.i, of 1.0 and the medium was replaced as indicated. Extracellular and intracellular virus was harvested at 4 days post-infection.
Characterization of the low molecular mass FCS factor responsible for the increase in infectious extracellular virus
The low molecular mass fraction of FCS was further separated on a Sephadex G-75 column and every fifth fraction was added to cell culture medium after adsorption of CMV strain AD 169. The amount of infectious extracellular virus was assayed at 4 days post-infection and it can be seen that this was markedly increased when fractions 95 or 100 were added (Fig. 3) . The remaining fractions did not increase viral titres above the background level. Thus the component of FCS which when added to culture medium could enhance the amount of infectious extracellular virus had a molecular mass around 10000 daltons, which is virtually identical to that of bovine fl2m.
Output of CMV strain AD169 from cells cultured in the presence of flzm or FCS fractions
The above experiments demonstrated that the amount of infectious virus found in the cell culture fluid was greater if human 132 m, or an FCS fraction corresponding to the molecular mass of bovine flzm, was present in the culture medium. To investigate whether this effect was due to an increase in the output of virus from cells or to an increase in the ratio of infectious to noninfectious particles, metabolic labelling experiments were conducted. Fibroblasts grown in * Fibroblasts were cultured in serum-free medium, infected with CMV strain AD169 at a m.o.i, of 1-0 and the medium was replaced with that indicated. At 4 days post-infection the medium was replaced with methionine-free medium and [3sS]methionine added for 24 h, after which time extracellular virus was harvested.
serum-free medium were infected with CMV strain AD 169 and the medium was replaced using the various supplements indicated in Table 2 . At 4 days post-infection the medium was replaced with methionine-free medium, and after 3 h [35S]methionine was added for 24 h. The amount of radiolabelled extracellular virus was measured and was assayed for infectivity ( Table 2 ). The output of [35S]methionine_labelled CMV was similar whether cells were cultured in serum-free medium or whether human fl2m, FCS or fractions of FCS were used as media supplements. However, the amount of infectious virus was significantly greater when FCS (P < 0.001), the low molecular mass fraction of FCS (P < 0.001), or to a lesser extent human fl2m (P < 0-001), was present in the culture medium (Table 2) . Thus human fl2m, or the FCS fraction containing bovine fl2m, when added to culture media do not affect the output of CMV from cells, but increase the infectivity of the virus present in extracellular fluids.
Competition between CMV and fl2m for binding sites on fibroblasts
Our previous observations that CMV had the capacity to bind 32m, and the finding here that 32m enhanced the infectivity of CMV, suggested that the virus was using this host protein to bind to cells. We have therefore investigated whether CMV and 32m share the same binding sites on fibroblasts using competitive inhibition studies. Fig. 4 (a and b) shows that the binding of 125I-labelled urinary CMV to fibroblasts at 0 °C can be competitively inhibited by unlabelled CMV strain AD169 (grown in the presence of FCS) (P < 0.001), but not by unlabelled herpes simplex virus; thus the binding sites are virus-specific. In contrast, the binding of radiolabelled urinary CMV to fibroblasts could not be competitively inhibited by the binding of unlabelled free purified human 32 m (Fig. 4 b) . The binding of radiolabelled 32m to fibroblasts at 0 °C could be competitively inhibited by unlabelled urinary CMV or CMV strain AD169 (Fig. 4c) . Such competitive inhibition was not observed at 37 °C when internalization can take place (results not shown). Thus our results clearly demonstrate that urinary CMV, CMV strain AD169 and free 32m compete for the same binding sites on fibroblasts, although the affinity of either virus preparation appears to be greater than that of free 32m.
Binding of CMV to Daudi and Raft cells
The main binding site on cells for free 32m is the class I HLA molecule and we therefore compared the binding of CMV to cells expressing (Raji) or lacking (Daudi) the expression of class I HLA. The monoclonal antibodies W6/32 and BBM. 1 specific for class I HLA heavy chain and 32m respectively were used to check the cell surface expression of these molecules; Raft ceils showed good expression of these antigens whereas Daudi cells gave negative results (Fig. 5) .
The binding of 125I-labelled urinary CMV, CMV strain AD 169 or/~2 m to Daudi and Raji cells is shown in Fig. 6 . It can be seen that both the urinary virus and CMV strain AD169 bind significantly better to Raji cells than to Daudi cells (Fig. 6a, b) . The order of difference in the binding of the virus to the two cell lines is similar to that of radiolabelled/~,m (Fig. 6c) . It is worthy of note that although Daudi cells do not express class I HLA they can still bind f12 m, although to a significantly lesser degree than Raji cells, and similar results were obtained for CMV. These results clearly show that the presence of class I HLA molecules on the cell surface significantly increases the binding of urinary CMV or cell culture-grown CMV, indicating that CMV can use the class I HLA molecule as a receptor.
Competition between CMV and fl2m for binding sites on Raft and Daudi cells
The binding of radiolabelled urinary CMV to both Raji and Daudi cells was specific as shown by the competitive inhibition by unlabelled CMV strain AD169 (Fig. 7) . However, unlabelled flEm could not compete with the labelled virus for the binding sites on either cell line (Fig. 7) . In contrast, CMV strain AD169 could competitively inhibit the binding of radiolabeUed f12 m to Raji cells (Fig. 8) , as did unlabelled flzm. However, neither CMV strain AD169 nor fiE m could act as competitors for the binding of labelled fiE m to Daudi cells. Thus urinary CMV, CMV strain AD169 and fl2m compete for the same binding sites on Raji cells. The results also demonstrate that, as observed with fibroblasts, the affinity of the binding of fiE m to Raji cells is less than that of the virus preparations.
Comparison of CMV infection in Daudi and Raft cells
It was important to establish whether both the class I HLA-mediated binding of CMV, exemplified by the increased binding to Raji cells, and the non-HLA binding of CMV, seen with Daudi cells, led to internalization of the virus and infection of cells. Unfortunately neither cell line is fully permissive for CMV replication, but we could use CMV early antigen expression as a marker of initiation of infection. We compared the proportion of Daudi or Raji cells which became infected with CMV strain AD169 using monoclonal antibodies specific for CMV early antigens, and immunofluorescence. Early antigens were rarely seen in Daudi cells with a total of 0-07 ~ of cells positive by immunofluorescence, whereas a tenfold increase in the proportion of cells infected was seen with the Raji cell line.
DISCUSSION
Our results clearly show that when fibroblasts arc grown in the presence of human f12 m the amount of infectious extracellular CMV is enhanced compared to that found when cells are grown in serum-free medium. All assays of infectious virus were performed using cells grown in serum-free medium, so that differences in the endpoint titre represented solely differences in the initial inoculum. FCS added to culture media could also enhance the amount of infectious virus, and further studies clearly showed that the component of FCS responsible for this effect had a molecular mass around 10000 daltons. This fraction corresponds to that which would contain bovine f12 m (molecular mass 11700 daltons), a known constituent of FCS (Ziegler & Milstein, 1979) . Thus we conclude that the presence of human or bovine f12 m in cell culture media enhances the amount of infectious extracellular CMV.
Metabolic labelling experiments demonstrated that equivalent amounts of extracellular virus were produced by cells cultured in medium devoid of f12 m or containing either human or bovine f12 m. Thus the obscrved differences were not due to nutritional deficiencies or other metabolic effects as a consequence of culturing cells in serum-free medium. Despite the equivalent amounts of extracellular virus released from cells, the amount of infectious virus present was considerably greater when human flEm, or especially when bovine fl2m, was present. Thus our results demonstratc that fl2m enhances the infectivity of CMV strain AD169 after release of the virus from cells. Since we have previously shown that CMV strain AD 169 binds exogenous fiE m of human or bovinc origin , we conclude that such binding enhances the infectivity of the virus.
It should be emphasized that although fl2m was not a component of the serum-free medium used, all cells can synthesize fl2m and we were able to measure up to 0-1 ~tg/ml f12 m released into the medium by the fibroblasts. Thus the use of serum-free medium serves only to reduce thc amount of fl2m present to the lowest concentration possible. We believe that the presence of endogenous fl2m may account for part of the background level of infectivity seen with virus harvested from cells grown in the absence of an exogenous sourcc of fiE m.
The most likely explanation for the increase in the infectivity of CMV as a consequence of the binding of fl2m is that the virus uses this host protein to bind to cells and initiate infection. This explanation is supported by our findings that urinary CMV, previously shown to be coated with fl2m (and confirmed by Western blotting; data not shown), could compete with free f12 m for binding to fibroblasts. Similar results were obtained for CMV strain AD 169 grown in the presence of bovine fiE m. Thus CMV and fiE m bind to the same, or spatially closely associated, sites on the cell surface.
flzm is the light chain of class I HLA molecules (Cresswell et al., 1974) and the main binding site known for fiE m on the cell surface is the heavy chain of class I HLA (Hyafil & Strominger, 1979) . We therefore predicted that, when complexed with fiE m, CMV could bind to class I HLA molecules on the cell surface. To verify this prediction we used a cell line, Daudi, which is deficient in the mRNA for f12 m (De Pr6val &Mach, 1983) and does not express class I HLA molecules on the cell surface (Sege et al., 1981 , and the present study). Our findings clearly demonstrated that the binding of urinary CMV, or CMV strain AD 169 grown in the presencc of FCS, to class I HLA-positive Raji cells was significantly greater than that to class I-negative Daudi cells. These results indicate that fl2m-coated CMV can bind to class I HLA molecules. Such binding was specific for the virus since it could be competitively inhibited by CMV strain AD169.
It should be noted that urinary CMV could also bind to Daudi cells, although to a lesser extent than to Raji cells. The binding of the virus to Daudi cells was specific as shown by the competitive inhibition experiments. However, although not expressing class I HLA antigens, Daudi cells could bind radiolabelled f12 m. This binding emphasizcs that there are other cell surface molecules which can bind fiE m, and these probably account for the binding to Daudi cells of f12 m-coated CMV. We are currently attempting to characterize these non-class I HLA fl2m-binding proteins.
The mechanism of the binding of the fl2m-CMV complex to class I HLA antigens is presumably by displacement of the flEm in the fiE m-heavy chain dimer on the cell surface, flEm is non-covalently bound to the heavy chain and does not have a transmembrane portion. Exchange of fl2m between the cell surface and the culture medium is well described (Hyafil & Strominger, 1979; Kefford et al., 1984; Bernabeu et al., 1984) and Sanderson et aL (1985) have shown that the exchange favours displacement of the cell surface fl2m. This was found to be especially the case if the f12 m in the medium was from a different species or was modified by iodination (Ward & Sanderson, 1983) or haptenation (Sanderson et al., 1985) . Thus it is likely that fiE m bound to CMV could readily displace cell surface fl2m. Our findings that CMV can competitively inhibit the binding of flEm to Raji cells or to fibroblasts, but that the reverse is not true, suggests that the virus has a higher binding affinity for the class I molecule than does free fl2m. Thus, the exchange of CMV-flEm for f12 m on the class I dimer would be favoured. When CMV is not coated with fl2m it is possible that the capacity of the virus to bind this protein would enable it to bind directly to the fl2m-heavy chain dimer on the cell surface. However, as all body fluids contain flEm, it is unlikely that uncoated CMV exists under physiological conditions.
The observations of Sanderson et al. (1985) may also explain our findings that bovine fiE m seemed to enhance infectivity of CMV to a greater extent than did human fl2m; possibly the virus-bound bovine fl2m was more efficient at displacing fiE m from cells. Alternatively since CMV strain AD169 has been passaged in vitro in the presence of FCS for many years it may have evolved to bind bovine f12 m more efficiently than human f12 m.
We postulate that once bound to class I HLA on the cell surface the large number of molecules of flzm on CMV (McKeating et al., 1986) would allow cross-linking of class I HLA heavy chains, and trigger internalization of the virus by receptor-mediated endocytosis. That the binding of CMV to cells via its envelope-bound fiE m leads to infection of cells is supported by our observations on the enhancement of infectivity by fie m. The important question which arises is whether the binding of CMV to the class I HLA heavy chain represents the major pathway of entry of CMV into cells or whether binding to non-HLA molecules, seen with Daudi cells, also leads to infection. Although the incidence of infection of Raji cells was tenfold higher than that seen with Daudi cells, the incidence of infection was too low in either cell line to draw any conclusions on this point. The non-permissive nature of most cells other than fibroblasts makes the appropriate in vitro studies difficult.
It is of interest that one of us (J.E.G.) has previously found that in the murine model of CMV infection, resistance to lethal infection with murine CMV maps to the class I regions of the H-2 complex, the equivalent of the HLA region in man [Chalmer et al., 1977; Chalmer, 1980; Grundy (Chalmer) et al., 1981 ] . We postulate that the binding of the virus-fl2m complex may be more effective in certain H-2 haplotypes, thus increasing their susceptibility. The fact that class I antigens are codominantly expressed and that susceptibility is the dominant trait in FI hybrids between resistant and susceptible mouse strains [Chalmer, 1980; Grundy (Chalmer) et al., 1981 ] , is consistent with this hypothesis. Furthermore, in support of this theory is the finding that resistance in recombinant mice of the B10 background is associated with possession of D b [Chalmer, 1980; Grundy (Chalmer) et al., 1981] and that this class I molecule may have reduced binding of fl2m, and can exist on the cell surface without being associated with fiE m (Potter et al., 1984 (Potter et al., , 1985 . Whether or not a similar effect is seen in man, with differential binding of CMV to various HLA haplotypes, is currently under investigation.
In conclusion, we have demonstrated that the presence of human or bovine fl2m in cell culture media enhances the infectivity of exIracellular CMV. We propose that fl2m binds to the virus as we have previously described, and that CMV uses the bound f12 m to bind to host cells. We have demonstrated that flEm and C MV compete for the same binding site on the surface of fibroblasts or Raji cells. In addition, we have shown that the flEm-coated virus can use class I HLA molecules on the surface of cells as a virus receptor. Future experiments are needed to determine whether class I HLA genes control resistance to CMV in man in a manner similar to that previously found in the mouse.
